Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions.

Bhattacharyya S, Hope TJ, Young JA.

Virology. 2011 Oct 10;419(1):1-9. doi: 10.1016/j.virol.2011.07.018. Epub 2011 Aug 19.

2.

Ebola virus uses clathrin-mediated endocytosis as an entry pathway.

Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, Hope TJ.

Virology. 2010 May 25;401(1):18-28. doi: 10.1016/j.virol.2010.02.015. Epub 2010 Mar 3.

3.

Filovirus entry: a novelty in the viral fusion world.

Hunt CL, Lennemann NJ, Maury W.

Viruses. 2012 Feb;4(2):258-75. doi: 10.3390/v4020258. Epub 2012 Feb 7. Review.

4.

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y.

PLoS Pathog. 2010 Sep 23;6(9):e1001121. doi: 10.1371/journal.ppat.1001121.

5.

Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15.

Pu Y, Zhang X.

J Virol. 2008 Aug;82(16):8112-23. doi: 10.1128/JVI.00837-08. Epub 2008 Jun 11.

6.

Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2.

Hamdan FF, Rochdi MD, Breton B, Fessart D, Michaud DE, Charest PG, Laporte SA, Bouvier M.

J Biol Chem. 2007 Oct 5;282(40):29089-100. Epub 2007 Aug 3.

7.
8.

The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis.

Keyel PA, Thieman JR, Roth R, Erkan E, Everett ET, Watkins SC, Heuser JE, Traub LM.

Mol Biol Cell. 2008 Dec;19(12):5309-26. doi: 10.1091/mbc.E08-07-0712. Epub 2008 Oct 8.

9.

Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.

Spence JS, Krause TB, Mittler E, Jangra RK, Chandran K.

MBio. 2016 Feb 9;7(1):e01857-15. doi: 10.1128/mBio.01857-15.

10.

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.

Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C.

Cell Res. 2008 Feb;18(2):290-301. doi: 10.1038/cr.2008.15.

11.

Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.

Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.

J Virol. 2011 Sep;85(17):8502-13. doi: 10.1128/JVI.02600-10. Epub 2011 Jun 22.

12.

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.

J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.

13.

Comprehensive analysis of ebola virus GP1 in viral entry.

Manicassamy B, Wang J, Jiang H, Rong L.

J Virol. 2005 Apr;79(8):4793-805.

14.

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.

Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR.

Nature. 2011 Aug 24;477(7364):340-3. doi: 10.1038/nature10348.

15.

Eps15 and Epsin1 are crucial for enteropathogenic Escherichia coli pedestal formation despite the absence of adaptor protein 2.

Lin AE, Benmerah A, Guttman JA.

J Infect Dis. 2011 Sep 1;204(5):695-703. doi: 10.1093/infdis/jir386. Epub 2011 Aug 2.

PMID:
21810914
16.

The endocytic adaptor protein Disabled-2 is required for cellular uptake of fibrinogen.

Hung WS, Huang CL, Fan JT, Huang DY, Yeh CF, Cheng JC, Tseng CP.

Biochim Biophys Acta. 2012 Oct;1823(10):1778-88. doi: 10.1016/j.bbamcr.2012.06.008. Epub 2012 Jun 15.

17.

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.

O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L.

J Virol. 2015 May;89(10):5441-9. doi: 10.1128/JVI.03689-14. Epub 2015 Mar 4.

18.

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.

Chan SY, Speck RF, Ma MC, Goldsmith MA.

J Virol. 2000 May;74(10):4933-7.

19.

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

Martinez O, Ndungo E, Tantral L, Miller EH, Leung LW, Chandran K, Basler CF.

J Virol. 2013 Mar;87(6):3324-34. doi: 10.1128/JVI.01598-12. Epub 2013 Jan 9.

20.

Supplemental Content

Support Center